Business Context and Reporting Period
This Form 8-K was filed by ACM Research, Inc. on December 15, 2020. The company, an emerging growth company incorporated in Delaware, operates principally through its subsidiary, ACM Research (Shanghai), Inc. The filing addresses the status of the planned listing of ACM Shanghai on the Shanghai Stock Exchange's Sci-Tech innovAtion boaRd (STAR Market) and a concurrent initial public offering (STAR IPO).
Key Financial Metrics
This filing is a current report regarding regulatory progress and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Regulatory Status
- SSEC Review Completed: The Shanghai Securities and Exchange Commission (SSEC) completed its review of a verification report submitted by the lead underwriter of the STAR IPO.
- Verification Report: The report addressed allegations regarding the company's business and operations contained in a report issued by J Capital Research USA Ltd. on October 8, 2020. An English translation of this report is included as Exhibit 99.01.
- Target Timeline: The company targets completion of the STAR IPO in the first quarter of 2021, pending review and registration by the China Securities Regulatory Commission (CSRC) and subject to market conditions.
Outlook, Risks, and Contingencies
Management notes that the STAR Listing and STAR IPO may not be completed on the targeted schedule or at all due to factors outside the company's control. Specific risks include:
- Potential denial or significant delay of registration approval by the CSRC.
- Exacerbation of delays due to the continuing COVID-19 pandemic in China and globally.
- Regulatory restrictions: The ACM Shanghai shares offered in the STAR IPO are not registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable exemption.
Investor Verification Checklist
- Verify the content of the Verification Report (Exhibit 99.01) regarding the J Capital Research allegations.
- Monitor the status of the registration review by the China Securities Regulatory Commission (CSRC).
- Assess the impact of the COVID-19 pandemic on the timeline for the STAR IPO.
- Confirm that the STAR IPO shares are not available for purchase in the United States.